IN this issue Ratcheson and Ommaya report on the use of their device, which consists of a subcutaneous plastic bubble, connected to a plastic catheter that lies in one of the cerebral ventricles.

Approximately one year after the company landed FDA approval for its Ventricular Assist System, the company is boasting significant surge in revenue. In early morning trading on November 7, the ...

PLEASANTON, Calif. -- Thoratec Corporation, a world leader in device-based mechanical circulatory support therapies to save, support and restore failing hearts, said today it has acquired the ...

Please provide your email address to receive an email when new articles are posted on . The FDA and Medtronic alerted health care providers to no longer implant patients with end-stage HF with a ...

SAN RAMON, Calif.--(BUSINESS WIRE)--BioVentrix, Inc., a privately-held company with a first-in-class, transcatheter-based structural heart device to treat heart failure, today announced that the U.S.

SIAM Journal on Applied Mathematics, Vol. 72, No. 5 (2012), pp. 1618-1643 (26 pages) An efficient bidomain model of electrical activity in cardiac specialized conduction system fibers is developed and ...

MINNEAPOLIS - Medtronic, Inc. today announced market release of the CardioGuide (TM) Implant System, a novel real-time navigation system for cardiac resynchronization therapy pacemakers and ...

FRAMINGHAM, Mass. and SYDNEY, Jan. 9, 2012 /PRNewswire/ -- HeartWare International, Inc. (NASDAQ: HTWR - ASX: HIN), a leading innovator of less invasive, miniaturized circulatory support technologies ...

With approval, the HeartMate 3 System offers physicians in Europe the most advanced ventricular assist technology available to support the management of patients with advanced stage heart failure ST.

Abstract: The primary objective of this project is to design, fabricate, and test a small, integrated camera system for aiding in the visualization and surgical repair of certain types of ventricular ...